September 8, 2025
Willkie is serving as transaction counsel to Churchill Capital Corp X (NASDAQ: CCCX), a publicly traded special purpose acquisition company, in its business combination with Infleqtion, a global leader in neutral atom-based quantum technology.
On September 8, Churchill Capital Corp X and Infleqtion announced that they entered into a definitive business combination agreement, through which Infleqtion will become a publicly traded company. The transaction aims to accelerate Infleqtion’s mission to commercialize quantum products that provide orders of magnitude improvement in computing and precision sensing applications.
The business combination values Infleqtion at a pre-money equity value of $1.8 billion and is expected to provide more than $540 million of gross proceeds to the company.
The Willkie team is led by partners Gregory Astrachan, Sean Ewen and Esther Chang and includes associates Marissa Dressor, Andrew Lefkowitz, Bridget Boyd and Alanah Herfi.
On September 8, Churchill Capital Corp X and Infleqtion announced that they entered into a definitive business combination agreement, through which Infleqtion will become a publicly traded company. The transaction aims to accelerate Infleqtion’s mission to commercialize quantum products that provide orders of magnitude improvement in computing and precision sensing applications.
The business combination values Infleqtion at a pre-money equity value of $1.8 billion and is expected to provide more than $540 million of gross proceeds to the company.
The Willkie team is led by partners Gregory Astrachan, Sean Ewen and Esther Chang and includes associates Marissa Dressor, Andrew Lefkowitz, Bridget Boyd and Alanah Herfi.
